Jenner P, Marsden C D
Adv Biochem Psychopharmacol. 1982;32:85-103.
It can be said that sulpiride exerts a disinhibitory effect in both depression and schizophrenia but this is not associated with mechanisms through which typical antidepressant or anxiolytic agents act. Sulpiride acts selectively as a dopamine receptor antagonist in the brain, its effects on other neuronal systems being extremely limited. Indeed, it may act even selectively within the dopamine systems in that it would appear it specifically interacts with one sub-population of cerebral dopamine receptors. Within a given dopamine receptor system sulpiride may exert a differential pre-synaptic action on dopamine neurones although the evidence for this remains controversial. The disinhibitory effects in depression may be due to a preferential pre-synaptic action of the drug on dopamine neurones causing over-activation of cerebral dopamine post-synaptic receptors causing behavioural arousal and motor facilitation. On the other hand, the disinhibitory effect of sulpiride in schizophrenia may also involve the preferential pre-synaptic action of the drug coupled with the specificity of post-synaptic action to result in little sedation or motor retardation. Sulpiride may also differentially antagonise post-synaptic dopamine receptors in different brain areas and this may also be critically involves in its unusual spectrum of neuroleptic action.
可以说,舒必利在抑郁症和精神分裂症中均发挥去抑制作用,但这与典型抗抑郁药或抗焦虑药的作用机制无关。舒必利在大脑中选择性地作为多巴胺受体拮抗剂起作用,其对其他神经元系统的作用极为有限。实际上,它甚至可能在多巴胺系统内具有选择性作用,因为它似乎与脑多巴胺受体的一个亚群特异性相互作用。在给定的多巴胺受体系统中,舒必利可能对多巴胺神经元产生不同的突触前作用,尽管对此的证据仍存在争议。抑郁症中的去抑制作用可能是由于该药物对多巴胺神经元的优先突触前作用,导致脑多巴胺突触后受体过度激活,从而引起行为觉醒和运动促进。另一方面,舒必利在精神分裂症中的去抑制作用可能也涉及该药物的优先突触前作用以及突触后作用的特异性,从而导致很少的镇静或运动迟缓。舒必利还可能在不同脑区对突触后多巴胺受体产生不同的拮抗作用,这也可能在其不寻常的抗精神病作用谱中起关键作用。